Table 1 Patient characteristics and surgical outcomes of bipolar transurethral electro vaporization of the prostate (B-TUVP) and holmium laser enucleation of the prostate (HoLEP) in patients with prostate volume of 30–80 ml
B-TUVP | HoLEP | P value * | ||
|---|---|---|---|---|
All patients | N=75 | N=166 | ||
Age(years-old) | 76.4 ± 6.8 | 71.5 ± 7.4 | <0.001 | |
Prostate volume (ml) | 57.3 ± 14.8 | 56.0 ± 14.2 | 0.5 | |
Operative time (mins) | 93.7 ± 22.8 | 125.3 ± 36.7 | <0.001 | |
Duration of post-operative catheterisation (days) | 2.6 ± 1.1 | 2.3 ± 1.9 | 0.3 | |
Hospital stay period after operation (days) | 5.9 ± 2.4 | 6.7 ± 2.5 | 0.018 | |
Hemoglobin (g/dl) | Change (%) | 96.0 ± 1.4 | 90.4 ± 5.7 | <0.001 |
Necessity of 2nd procedure | 2 (2.7%) | 0 | 0.034 | |
Uncatheterised patients | N = 45 | N = 135 | ||
Total IPSS | Pre | 22.3 ± 7.2 | 22.1 ± 7.2 | 0.9 |
1POM | 13.3 ± 7.9 | 9.3 ± 6.3 | 0.004 | |
Change (%) at 1POM | 69.3 ± 43.3 | 45.1 ± 32.7 | 0.008 | |
3POM | 9.8 ± 7.4 | 6.7 ± 5.2 | 0.018 | |
Change (%) at 3POM | 46.0 ± 34.8 | 36.3 ± 39.2 | 0.1 | |
IPSS-QoL | Pre | 5.2 ± 1.0 | 4.8 ± 1.1 | 0.09 |
1POM | 3.5 ± 1.8 | 3.0 ± 1.6 | 0.1 | |
Change (%) at 1POM | 69.1 ± 39.9 | 68.6 ± 53.3 | 0.7 | |
3POM | 2.6 ± 1.7 | 2.1 ± 1.5 | 0.1 | |
Change (%) at 3POM | 53.0 ± 32.9 | 37.1 ± 30.0 | 0.06 | |
Catheterised patients | N = 30 | N = 31 | ||
Achieving catheter free status after surgery | 20 (67%) | 27 (87%) | 0.06 |